Safety, Blood Levels and Effects of GW642444
NCT00469040
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
GW642444M for 14 days
Sponsor
GlaxoSmithKline